Reuters logo
Actelion says enters into exclusive discussions with J&J
December 21, 2016 / 4:50 PM / a year ago

Actelion says enters into exclusive discussions with J&J

ZURICH, Dec 21 (Reuters) - Actelion said on Wednesday it has entered exclusive negotiations with U.S. healthcare company Johnson & Johnson regarding what the Swiss biotech company called a “possible strategic transaction”.

Actelion, which has previously been courted by French drugmaker Sanofi as well as J&J, said “there can be no assurance any transaction will result from these discussions.”

J&J confirmed the exclusive negotiations. (Reporting by John Revill; Editing by Michael Shields)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below